Login / Signup

Efficacy and Safety of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia: Phase 3, Multinational Open-Label Study.

Éric BruckertSonia CaprioAlbert WiegmanMin-Ji CharngCézar A Zárate-MoralesMarie T Baccara-DinetGaren ManvelianAnne OurliacMichel ScemamaStephen R Daniels
Published in: Arteriosclerosis, thrombosis, and vascular biology (2022)
gov; NCT03510715.
Keyphrases
  • open label
  • randomized controlled trial
  • squamous cell carcinoma
  • study protocol
  • phase ii
  • phase ii study